Business · 27/08/2013

FDA Releases Draft Guidance on Stability Testing for Generic Drug Applications

The Food and Drug Administration (FDA) has published a draft guidance document addressing stability testing recommendations for abbreviated new drug applications (ANDAs), in response to public comments and in line with International Conference on Harmonisation (ICH) guidelines Q1A (R2) through Q1E.